<?xml version='1.0' encoding='utf-8'?>
<document id="31366830"><sentence text="Effect of Drug Combination on Omeprazole Metabolism by Cytochrome P450 2C19 in Helicobacter pylori Eradication Therapy."><entity charOffset="30-40" id="DDI-PubMed.31366830.s1.e0" text="Omeprazole" /></sentence><sentence text="Helicobacter pylori (H" /><sentence text=" pylori) infection is common and can result in gastric and duodenal ulcers, and in some cases, gastric lymphoma and cancer" /><sentence text=" Omeprazole (OMP)-in combination with clarithromycin (CLR), amoxicillin (AMX), tinidazole (TND), or metronidazole (MET)-is used in double or triple combination therapy for eradication of H"><entity charOffset="1-11" id="DDI-PubMed.31366830.s4.e0" text="Omeprazole" /><entity charOffset="38-52" id="DDI-PubMed.31366830.s4.e1" text="clarithromycin" /><entity charOffset="54-57" id="DDI-PubMed.31366830.s4.e2" text="CLR" /><entity charOffset="60-71" id="DDI-PubMed.31366830.s4.e3" text="amoxicillin" /><entity charOffset="73-76" id="DDI-PubMed.31366830.s4.e4" text="AMX" /><entity charOffset="79-89" id="DDI-PubMed.31366830.s4.e5" text="tinidazole" /><entity charOffset="91-94" id="DDI-PubMed.31366830.s4.e6" text="TND" /><entity charOffset="100-113" id="DDI-PubMed.31366830.s4.e7" text="metronidazole" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e0" e2="DDI-PubMed.31366830.s4.e0" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e0" e2="DDI-PubMed.31366830.s4.e1" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e0" e2="DDI-PubMed.31366830.s4.e2" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e0" e2="DDI-PubMed.31366830.s4.e3" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e0" e2="DDI-PubMed.31366830.s4.e4" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e0" e2="DDI-PubMed.31366830.s4.e5" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e0" e2="DDI-PubMed.31366830.s4.e6" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e0" e2="DDI-PubMed.31366830.s4.e7" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e1" e2="DDI-PubMed.31366830.s4.e1" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e1" e2="DDI-PubMed.31366830.s4.e2" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e1" e2="DDI-PubMed.31366830.s4.e3" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e1" e2="DDI-PubMed.31366830.s4.e4" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e1" e2="DDI-PubMed.31366830.s4.e5" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e1" e2="DDI-PubMed.31366830.s4.e6" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e1" e2="DDI-PubMed.31366830.s4.e7" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e2" e2="DDI-PubMed.31366830.s4.e2" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e2" e2="DDI-PubMed.31366830.s4.e3" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e2" e2="DDI-PubMed.31366830.s4.e4" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e2" e2="DDI-PubMed.31366830.s4.e5" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e2" e2="DDI-PubMed.31366830.s4.e6" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e2" e2="DDI-PubMed.31366830.s4.e7" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e3" e2="DDI-PubMed.31366830.s4.e3" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e3" e2="DDI-PubMed.31366830.s4.e4" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e3" e2="DDI-PubMed.31366830.s4.e5" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e3" e2="DDI-PubMed.31366830.s4.e6" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e3" e2="DDI-PubMed.31366830.s4.e7" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e4" e2="DDI-PubMed.31366830.s4.e4" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e4" e2="DDI-PubMed.31366830.s4.e5" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e4" e2="DDI-PubMed.31366830.s4.e6" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e4" e2="DDI-PubMed.31366830.s4.e7" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e5" e2="DDI-PubMed.31366830.s4.e5" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e5" e2="DDI-PubMed.31366830.s4.e6" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e5" e2="DDI-PubMed.31366830.s4.e7" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e6" e2="DDI-PubMed.31366830.s4.e6" /><pair ddi="false" e1="DDI-PubMed.31366830.s4.e6" e2="DDI-PubMed.31366830.s4.e7" /></sentence><sentence text=" pylori" /><sentence text=" However, the roles of the drugs other than OMP are not clearly understood" /><sentence text=" Therefore, in the present study, we aimed to investigate any effects of these drugs on OMP metabolism by wild-type CYP2C19 using spectroscopy and enzyme kinetics" /><sentence text=" The dissociation constants (Kd) for CYP2C19 with OMP, CLR, AMX, TND, and MET were 8"><entity charOffset="60-63" id="DDI-PubMed.31366830.s8.e0" text="AMX" /><entity charOffset="55-57" id="DDI-PubMed.31366830.s8.e1" text="CLR" /><entity charOffset="65-67" id="DDI-PubMed.31366830.s8.e2" text="TND" /><pair ddi="false" e1="DDI-PubMed.31366830.s8.e1" e2="DDI-PubMed.31366830.s8.e1" /><pair ddi="false" e1="DDI-PubMed.31366830.s8.e1" e2="DDI-PubMed.31366830.s8.e0" /><pair ddi="false" e1="DDI-PubMed.31366830.s8.e1" e2="DDI-PubMed.31366830.s8.e2" /><pair ddi="false" e1="DDI-PubMed.31366830.s8.e0" e2="DDI-PubMed.31366830.s8.e0" /><pair ddi="false" e1="DDI-PubMed.31366830.s8.e0" e2="DDI-PubMed.31366830.s8.e2" /></sentence><sentence text="6, 126, 156, 174, and 249 µM, respectively" /><sentence text=" The intrinsic clearance of OMP was determined to be 355 mL/min/µmol of CYP2C19" /><sentence text=" Metabolism of OMP was significantly inhibited by 69, 66, 28, and 40% in the presence of CLR, TND, AMX, and MET, respectively"><entity charOffset="89-91" id="DDI-PubMed.31366830.s11.e0" text="CLR" /><entity charOffset="99-101" id="DDI-PubMed.31366830.s11.e1" text="AMX" /><entity charOffset="94-96" id="DDI-PubMed.31366830.s11.e2" text="TND" /><pair ddi="false" e1="DDI-PubMed.31366830.s11.e0" e2="DDI-PubMed.31366830.s11.e0" /><pair ddi="false" e1="DDI-PubMed.31366830.s11.e0" e2="DDI-PubMed.31366830.s11.e2" /><pair ddi="false" e1="DDI-PubMed.31366830.s11.e0" e2="DDI-PubMed.31366830.s11.e1" /><pair ddi="false" e1="DDI-PubMed.31366830.s11.e2" e2="DDI-PubMed.31366830.s11.e2" /><pair ddi="false" e1="DDI-PubMed.31366830.s11.e2" e2="DDI-PubMed.31366830.s11.e1" /></sentence><sentence text=" Moreover, the combination of CLR and TND resulted in 76% inhibition of OMP metabolism, while the combination of AMX and MET resulted in 48% inhibition of OMP metabolism"><entity charOffset="30-32" id="DDI-PubMed.31366830.s12.e0" text="CLR" /><entity charOffset="113-115" id="DDI-PubMed.31366830.s12.e1" text="AMX" /><entity charOffset="38-40" id="DDI-PubMed.31366830.s12.e2" text="TND" /><pair ddi="false" e1="DDI-PubMed.31366830.s12.e0" e2="DDI-PubMed.31366830.s12.e0" /><pair ddi="false" e1="DDI-PubMed.31366830.s12.e0" e2="DDI-PubMed.31366830.s12.e2" /><pair ddi="false" e1="DDI-PubMed.31366830.s12.e0" e2="DDI-PubMed.31366830.s12.e1" /><pair ddi="false" e1="DDI-PubMed.31366830.s12.e2" e2="DDI-PubMed.31366830.s12.e2" /><pair ddi="false" e1="DDI-PubMed.31366830.s12.e2" e2="DDI-PubMed.31366830.s12.e1" /></sentence><sentence text=" Both combinations of drugs not only have antibacterial effects, but also enhance the effect of OMP by inhibiting its metabolism by CYP2C19" /><sentence text=" These results indicate that drug-drug interactions of co-administered drugs can cause complex effects, providing a basis for OMP dose adjustment when used in combination therapy for H" /><sentence text=" pylori eradication" /><sentence text="" /></document>